Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2035 of 6351
-
New drug takes on KRAS: early trial launches for Hard-to-Treat cancers
Disease control OngoingThis is a study in adults with advanced cancer (solid tumours) in whom previous chemotherapy was not successful. Only people who have a tumour with a KRAS mutation can participate in the study. A KRAS mutation makes cancer grow faster. The study tests 2 medicines called BI 17019…
Phase 1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New drug hope for patients with advanced cancers
Disease control Recruiting nowThis is a single group study of participants with advanced solid tumors who have not been cured by other treatments. It is the first time the drug will be used in humans, and will be in two parts. The primary purpose of the parts are: * Dose Escalation Part: To evaluate the saf…
Phase 1/2 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can cutting carbs reshape the Body's sugar response?
Knowledge-focused CompletedThe goal of this study is to test whether a low-carbohydrate diet (LCD), comparred with a Mediterranean diet (MED) producing similar weight loss, differentially affects fasting and postprandial glucose metabolism in individuals with overweight and dysglycemia. The main questions …
Sponsor: Azienda Ospedaliero, Universitaria Pisana • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Natural vitamin e pill may delay liver transplant in cirrhosis patients
Disease control CompletedThe purpose of this Phase 2 trial is to validate the outcome observed in a previous trial that oral Tocotrienol (TCT) attenuates the rise in MELD score over time in patients with end stage liver disease / cirrhosis. The study is double blind and participants will be randomized to…
Phase 2 • Sponsor: Chandan Sen • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Flu shot linked to fewer deaths after fractures in seniors
Prevention CompletedBackground: Both influenza and bone fractures are significant contributors to morbidity and mortality among older adults. This study evaluated the associations between influenza vaccination (IV) and adverse outcomes following fracture-related hospitalizations in elderly individua…
Sponsor: Taipei Medical University Hospital • Aim: Prevention
Last updated Jun 27, 2026 07:58 UTC
-
Immunotherapy combo targets rare, aggressive lung cancer
Disease control CompletedLarge-cell neuroendocrine carcinoma (LCNEC) of the lung is a rare and aggressive malignancy with limited prospective evidence to guide systemic treatment. This prospective, non-randomized, real-world study evaluated the effectiveness and safety of atezolizumab in combination with…
Phase 1 • Sponsor: Oncology Center of Biochemical Education And Research • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Can a classroom program keep teen depression at bay?
Prevention CompletedThis study aims to test the feasibility of implementing an Icelandic cognitive-behavioral program designed to prevent depression, called "Thoughts and Health" in a Swedish school setting. The investigators will also evaluate whether implementation of the program has an impact on …
Sponsor: Vastra Gotaland Region • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
FitBit coaching may help amputees walk more after surgery
Symptom relief CompletedThe purpose of this study is to determine if walking biobehavioral intervention improves physical activity after dysvascular lower limb amputation.
Sponsor: University of Colorado, Denver • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Could abemaciclib be the next weapon against Hard-to-Treat gut tumors?
Disease control OngoingThis phase II trial studies how well abemaciclib works in treating patients with digestive system neuroendocrine tumors that have spread to other places in the body, do not respond to treatment, and cannot be removed by surgery. Abemaciclib may stop the growth of tumor cells by b…
Phase 2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New drug targets liver damage in rare genetic disease
Disease control CompletedThe purpose of this study is to evaluate the the safety and efficacy of the investigational product, fazirsiran (TAK-999, ARO-AAT), administered subcutaneously to patients with alpha-1 antitrypsin deficiency associated liver disease (AATD).
Phase 2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Could a constipation drug help fight colorectal cancer?
Disease control OngoingThis phase II trial studies the how well linaclotide works in treating patients with stages 0-3 colorectal cancer. Linaclotide is a very small protein that binds to receptors on intestinal cells and makes them secrete water and salt.
Phase 2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New drug could slow lung decline in transplant patients
Disease control CompletedLung transplantation (TxP) is now a validated treatment of end-stage pulmonary diseases, but long-term graft and patient survival are still hampered by the development of chronic allograft dysfunction (CLAD) affecting \> 50% of patients. The investigators propose to conduct a ph…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 26, 2026 14:53 UTC
-
Could seeing your own health data improve cancer care?
Knowledge-focused OngoingThe purpose of this research protocol is to measure Patient Reported Outcome Measures (PROMs) in breast cancer patients. PROM results will be provided to patients and providers and the investigators will evaluate the relationship between patient engagement with PROM results and p…
Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated Aug 28, 2026 00:00 UTC
-
New registry aims to boost lung transplants by reconditioning donor lungs
Disease control OngoingThe XVIVO Registry is to collect standard of care clinical data from "all-comers" who are transplanted with an EVLP lung treated with the XVIVO Perfusion System™ in order to assess the long-term performance of the device, and monitor device-related serious adverse events. In addi…
Sponsor: XVIVO Perfusion • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Dancing with a partner may boost brain and body in early Alzheimer's
Symptom relief CompletedInterventions that affect many different aspects of human ability rather than just one aspect of human health are more likely to be successful in preventing and treating Alzheimer's disease (AD). Functional decline in AD is severely impacted by impaired ability to do physical act…
Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Can a peer coach help young people take control of their chronic illness?
Disease control CompletedThe purpose of this study is to test the efficacy of a peer support coaching intervention to improve activated chronic illness self-management versus an attention control group in 225 adolescents and young adults with childhood onset chronic conditions.
Sponsor: Duke University • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Can a pill calm the immune attack in MS? a trial looks inside the spinal fluid
Disease control CompletedThe purpose of this study is to better understand the mechanism of action (MoA) of cladribine tablets by exploring the effect on central nervous system (CNS) and blood biomarkers relevant in the relapsing forms of multiple sclerosis (RMS; to include relapsing-remitting MS \[RRMS\…
Phase 4 • Sponsor: Gregory Wu • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New drug shows promise against rare salivary gland cancer
Disease control OngoingThis is a phase I/II trial to evaluate the efficacy of APG-115 +/- Carboplatin for the treatment p53 wild-type malignant salivary gland cancer. Part 1 consisted of 2 arms, arm A (APG-115 monotherapy) and arm B (APG-115 + Carboplatin) and was terminated early. Part 2 is a single…
Phase 1/2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Supercharged flu vaccine shows promise for seniors
Prevention CompletedPrimary Objective: To demonstrate that high-dose quadrivalent influenza vaccine (QIV-HD) induces an immune response that is superior to the responses induced by standard-dose quadrivalent influenza vaccine (QIV-SD) for all 4 virus strains 28 days post-vaccination in participants…
Phase 3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Prevention
Last updated Jun 26, 2026 16:38 UTC
-
Biopsy after ablation: a new way to catch hidden cancer?
Knowledge-focused Recruiting nowThis study will see whether collecting and analyzing needle biopsy samples from cancer liver metastases after a tumor ablation procedure will be able to identify cancer cells that are still alive. The results of these biopsies could help determine the next treatment for your canc…
Phase 2/3 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC